← Back to headlines

Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares

24/7 Wall St.·Mar 17

This story is reported by 24/7 Wall St.. Read what other outlets are saying below, then open the original report for full details.

View original report at 24/7 Wall St. ↗
Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares · NabkaNews